$447 Million is the total value of SECTOR GAMMA AS's 37 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRK | Sell | MERCK & CO INC | $37,775,000 | -7.8% | 414,338 | -17.0% | 8.45% | -5.0% |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $24,001,000 | -1.5% | 311,696 | -6.6% | 5.37% | +1.5% |
| BRKR | Sell | BRUKER CORP | $15,755,000 | -2.8% | 251,042 | -0.4% | 3.52% | +0.1% |
| CVS | Sell | CVS HEALTH CORP | $15,577,000 | -22.6% | 168,111 | -15.5% | 3.48% | -20.3% |
| CNC | Sell | CENTENE CORP DEL | $15,382,000 | -6.1% | 181,799 | -6.6% | 3.44% | -3.3% |
| NUVA | Sell | NUVASIVE INC | $12,167,000 | -19.3% | 247,502 | -7.0% | 2.72% | -17.0% |
| QGEN | Sell | QIAGEN NV | $9,522,000 | -11.4% | 201,729 | -8.0% | 2.13% | -8.7% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $6,249,000 | -35.4% | 42,844 | -27.7% | 1.40% | -33.5% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $6,125,000 | -12.2% | 165,439 | -12.2% | 1.37% | -9.7% |
| BIO | Sell | BIO RAD LABS INCcl a | $5,834,000 | -19.0% | 11,785 | -7.8% | 1.30% | -16.6% |
| PFE | Sell | PFIZER INC | $5,243,000 | -21.9% | 100,000 | -22.9% | 1.17% | -19.7% |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $2,727,000 | -60.4% | 27,077 | -43.0% | 0.61% | -59.2% |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -11,875 | -100.0% | -0.21% | – |
| XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -55,516 | -100.0% | -0.59% | – |
| PDCO | Exit | PATTERSON COS INC | $0 | – | -129,757 | -100.0% | -0.91% | – |
| BDX | Exit | BECTON DICKINSON & CO | $0 | – | -26,233 | -100.0% | -1.52% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -124,000 | -100.0% | -1.79% | – |
| ELAN | Exit | ELANCO ANIMAL HEALTH INC | $0 | – | -364,691 | -100.0% | -2.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.